ALEXIA POWELL: Open Payments
NPI 1750053088 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,723 in 87 payments from 20 companies in 2025. Trend: 2023 $1,521 · 2024 $2,090 · 2025 $1,723
Food & beverage: $1,723
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $377 |
| Janssen Biotech, Inc. | 16 | $322 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $182 |
| Madrigal Pharmaceuticals | 5 | $159 |
| GENZYME CORPORATION | 4 | $120 |
| Ardelyx, Inc. | 5 | $119 |
| Vanda Pharmaceuticals Inc. | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 4 | $64 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 4 | $36 |
Products named: TREMFYA, RINVOQ, DUPIXENT, REZDIFFRA, XIFAXAN, IBSRELA, SKYRIZI, FANAPT.
Industry payments across AL — which companies pay providers there.
